rhodioloside has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dai, Z; He, Z; Liu, X; Luo, S; Shi, Y; Zhou, M | 1 |
| Diao, W; Li, H; Lv, T; Peng, H; Shen, L; Wang, R; Zhang, N | 1 |
2 other study(ies) available for rhodioloside and Colitis
| Article | Year |
|---|---|
Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17/Treg imbalance.
Topics: Animals; Colitis; Colitis, Ulcerative; Dextran Sulfate; Dysbiosis; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; T-Lymphocytes, Regulatory; Triggering Receptor Expressed on Myeloid Cells-1 | 2023 |
Salidroside attenuates dextran sulfate sodium-induced colitis in mice via SIRT1/FoxOs signaling pathway.
Topics: Animals; Apoptosis; Colitis; Colon; Dextran Sulfate; Forkhead Transcription Factors; Glucosides; Male; Mice; Mice, Inbred C57BL; Organ Size; Oxidative Stress; Phenols; Signal Transduction; Sirtuin 1 | 2019 |